Aono T, Sakaguchi T, Tsukada K, Kurosaki I, Hatakeyama K
First Department of Surgery, Niigata University School of Medicine, Japan.
Dig Dis Sci. 1996 Jan;41(1):126-30. doi: 10.1007/BF02208593.
Plasma concentrations of ammonia were examined following prostaglandin E1 (PGE1) administration in 16 patients who received hepatectomy for hepatocellular carcinoma. PGE1 at 0.01-0.04 microgram/kg/min was administered for approximately 24 hr during the perioperative periods. The ammonia concentration was reduced a day after the operation following intravenous administration of PGE1 in cirrhotic patients compared to noncirrhotic patients with or without PGE1 injection. Serum liver function scores, glutamic pyruvic transaminase, and total bilirubin concentrations were decreased after PGE1 administration. A similar ammonia response due to PGE1 was obtained after operation in cirrhotic patient when PGE1 0.5 microgram/kg was administered intravenously for 30 min. These results suggest that PGE1 administration is useful in reducing the enhanced ammonia concentration associated with hepatic resection, and it is particularly effective in the case of liver cirrhosis.
对16例因肝细胞癌接受肝切除术的患者给予前列腺素E1(PGE1)后,检测其血浆氨浓度。在围手术期,以0.01 - 0.04微克/千克/分钟的剂量给予PGE1约24小时。与未注射或注射PGE1的非肝硬化患者相比,肝硬化患者静脉注射PGE1后,术后一天氨浓度降低。给予PGE1后,血清肝功能评分、谷丙转氨酶和总胆红素浓度均降低。在肝硬化患者术后静脉注射0.5微克/千克PGE1 30分钟后,也获得了类似的PGE1氨反应。这些结果表明,给予PGE1有助于降低与肝切除相关的升高的氨浓度,在肝硬化患者中尤其有效。